Jaguar Health, Inc. has taken a significant step by filing a registration statement to offer securities under the Securities Act of 1933. This move is aimed at enhancing the company's capital-raising capabilities, which is crucial for its ongoing operations and growth in the competitive pharmaceutical sector.
Background
Jaguar Health, Inc. is a company primarily engaged in the pharmaceutical preparations industry, classified under SIC code 2834. The company trades on the Nasdaq exchange under the ticker symbol JAGX. Its recent filings include various forms, with the latest being an S-3 registration statement filed on October 22, 2026.
What the Filing Says
The filing, accession number 0001193125-26-429100, indicates that Jaguar Health is looking to register securities, although specific details regarding the type or amount of securities were not disclosed in the filing.
Impact
This filing could potentially affect investors, stakeholders, and competitors within the pharmaceutical preparations industry. As Jaguar Health seeks to enhance its capital-raising efforts, other companies in the sector may need to adapt to the changing financial landscape.
What's Next
The filing does not say what happens next.
Company Information
Jaguar Health, Inc. is incorporated in Delaware and has its business address located at 200 Pine Street, Suite 400, San Francisco, CA 94104. The company can be contacted via phone at 415-371-8300. It operates under the Central Index Key (CIK) number 0001585608 and has a fiscal year ending on December 31.
Documents Filed
The registration statement includes various documents, such as the primary S-3 form, legal opinion (EX-5.1), and an auditor's consent (EX-23.1). Additionally, the filing contains information on filing fees and several graphics, which may be relevant for investors seeking comprehensive insights into the company's financial standing.
Filing Details
The filing was accepted by the SEC on the same day it was submitted, October 22, 2026, and comprises a total of 17 documents. The main document, the S-3, has a file size of 292,787 bytes, indicating a substantial amount of information provided to potential investors.
Missing Information
The filing does not specify the exact type or amount of securities being registered, nor does it elaborate on the intended use of the proceeds from the securities offering. Additionally, there is no mention of any specific timelines or strategies related to this capital-raising initiative.